- ¥6bn
- ¥4bn
- ¥2bn
- 78
- 43
- 12
- 38
Annual income statement for MRSO, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho |
Standards: | JAS | JAS | JAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 1,739 | 2,251 | 1,809 |
Cost of Revenue | |||
Gross Profit | 1,352 | 1,786 | 1,451 |
Selling / General / Administrative Expenses | |||
Research And Development | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 856 | 1,256 | 1,190 |
Operating Profit | 883 | 995 | 619 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 882 | 997 | 602 |
Provision for Income Taxes | |||
Net Income After Taxes | 651 | 654 | 388 |
Net Income Before Extraordinary Items | |||
Net Income | 651 | 654 | 388 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 651 | 654 | 388 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 184 | 185 | 110 |
Dividends per Share |